May 24, 2026, 2:02 PM EDT. IXICO PLC's CEO Bram Goorden discussed the company's interim results with Proactive, highlighting strong revenue growth. The firm, listed on the London Stock Exchange (LSE:IXI) and trading on OTC and Frankfurt exchanges, underscored its plans to expand its market presence. Goorden detailed strategies aiming to leverage IXICO's data analytics expertise within the clinical trial sector, signaling confidence in sustained growth. The company's focus remains on capitalizing on its position in healthcare technology, reinforcing its commitment to innovation and shareholder value.
